Best Momentum Stocks to Buy for September 10th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 10:
Eli Lilly and Company LLY: This pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.1% over the last 60 days.
Eli Lilly and Company Price and Consensus
Eli Lilly and Company price-consensus-chart | Eli Lilly and Company Quote
Eli Lilly's shares gained 5.0% over the last three months compared with the S&P 500’s advanced of 2.1%. The company possesses a Momentum Score of A.
Eli Lilly and Company Price
Eli Lilly and Company price | Eli Lilly and Company Quote
Moody's Corporation MCO: This risk assessment company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.1% over the last 60 days.
Moody's Corporation Price and Consensus
Moody's Corporation price-consensus-chart | Moody's Corporation Quote
Moody's shares gained 20.0% over the last three months compared with the S&P 500’s advanced of 2.1%. The company possesses a Momentum Score of A.
Moody's Corporation Price
Moody's Corporation price | Moody's Corporation Quote
Banco de Chile (BCH): This financial services company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.2% over the last 60 days.
Banco De Chile Price and Consensus
Banco De Chile price-consensus-chart | Banco De Chile Quote
Banco de Chile's shares gained 4.2% over the last three months compared with the S&P 500’s advanced of 2.1%. The company possesses a Momentum Score of A.
Banco De Chile Price
Banco De Chile price | Banco De Chile Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Moody's Corporation (MCO) : Free Stock Analysis Report
Eli Lilly and Company (LLY) : Free Stock Analysis Report